Medication Reconciliation in Oncologic Patients
- Conditions
- Medication Reconciliation
- Interventions
- Other: medication reconciliation
- Registration Number
- NCT04796142
- Brief Summary
To improve medication reconciliation in oncologic patients in healthcare transitions through an alliance between a Cancer Institute and the community pharmacies and a new integrated IT platform.
- Detailed Description
This trial will explore the alliance between a Cancer Institute and the community pharmacies to improve medication reconciliation in healthcare transitions, and will validate a new integrated IT platform.
Cancer patients receiving an oncologic treatment will be asked to choose a pharmacy participating to the trial, and to perform the pharmacological survey before every cycle of chemotherapy.
This will be sent through the new IT platform to the electronic medical record of IRST, and the Oncologist will perform the reconciliation.
Data about concomitant medications and possible interactions will be exensively analyzed.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 100
- Adult ≥18 years old
- Eastern Cooperative Oncology Group (ECOG) performance status ≤1
- Patients receiving an anticancer treatment
- Clear understanding of the Italian language; written informed consent.
- None
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Reconciliation medication reconciliation Interventional trial without drugs
- Primary Outcome Measures
Name Time Method medication recognition and reconciliation maintenance At day 1 of each cycle of treatment (each cycle might be 14, 21 or 28 days) number of reconciliations per patient
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Alessandro Passardi
🇮🇹Meldola, FC, Italy